BMAL1 and Parkinson disease: Although several findings support the therapeutic potential of metformin for age‐related diseases, including AD (Farr et al., 2019), PD (Mor et al., 2020), AS (Wu et al., 2021), and OA (Feng et al., 2020), involvement of Bmal1 is still poorly understood.